Diagast

Founded in 1990 and headquartered in Loos, France, Diagast is a private, revenue-generating company operating in the Diagnostics sector. It has established itself as a specialized player in the transfusion diagnostics market, providing critical reagents and instruments for blood group serology. The company's products are essential for pre-transfusion testing, ensuring compatibility and safety for patients. Diagast competes in a consolidated global market dominated by larger IVD corporations.

Serological immunohematology platform for blood typing, encompassing monoclonal/polyclonal antibody development, gel microcolumn and solid-phase assay technologies, and integrated instrument/software systems for transfusion diagnostics.

Diagast operates in a highly competitive market dominated by global players like Grifols (Ortho Clinical Diagnostics), Immucor, Bio-Rad, and Quotient. These competitors offer broad portfolios and high-throughput automation. Diagast's competitive strategy is likely based on specialization, customer intimacy, and providing cost-effective alternatives in specific regional markets or for particular product lines.